{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:47:41Z","timestamp":1765550861472,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13365-025-01286-3","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:18:05Z","timestamp":1761833885000},"page":"564-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA MCF2L-AS1 inhibits neuronal damage induced by 1-methyl-4-phenylpyridinium (MPP+) via regulating miR-28-5p"],"prefix":"10.1007","volume":"31","author":[{"given":"Dong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205\u2013214. https:\/\/doi.org\/10.1038\/nrd1330","journal-title":"Nat Rev Drug Discov"},{"key":"1286_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA (2019) Inflammation, infectious triggers, and parkinson\u2019s disease. Front Neurol 10:122. https:\/\/doi.org\/10.3389\/fneur.2019.00122","journal-title":"Front Neurol"},{"key":"1286_CR3","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.2147\/cmar.S313905","volume":"13","author":"M Cai","year":"2021","unstructured":"Cai M, Hu W, Huang C, Zhou C, Li J, Chen Y, Yu Y (2021) LncRNA MCF2L-AS1\/miR-105\/ IL-1\u03b2 axis regulates colorectal cancer cell oxaliplatin resistance. Cancer Manage Res 13:8685\u20138694. https:\/\/doi.org\/10.2147\/cmar.S313905","journal-title":"Cancer Manage Res"},{"key":"1286_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/15384101.2020.1747776","volume":"19","author":"Q Chen","year":"2020","unstructured":"Chen Q, Wang M, Wu S (2020) The lncrna MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a. Cell Cycle 19:1059\u20131065. https:\/\/doi.org\/10.1080\/15384101.2020.1747776","journal-title":"Cell Cycle"},{"key":"1286_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000518212","volume":"29","author":"C Chen","year":"2022","unstructured":"Chen C, Zhang S, Wei Y, Sun X (2022a) Lncrna RMST regulates neuronal apoptosis and inflammatory response via sponging miR-150-5p in parkinson\u2019s disease. Neuroimmunomodulation 29:55\u201362. https:\/\/doi.org\/10.1159\/000518212","journal-title":"Neuroimmunomodulation"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1080\/15384101.2022.2085359","volume":"21","author":"T Chen","year":"2022","unstructured":"Chen T, Wang H, Yan H (2022b) Mir-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Cell Cycle 21:2079\u20132090. https:\/\/doi.org\/10.1080\/15384101.2022.2085359","journal-title":"Cell Cycle"},{"key":"1286_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6078251","volume":"2019","author":"LM Chi","year":"2019","unstructured":"Chi LM, Wang LP, Jiao D (2019) Identification of differentially expressed genes and long noncoding RNAs associated with Parkinson\u2019s disease. Parkinson\u2019s Disease 2019:6078251. https:\/\/doi.org\/10.1155\/2019\/6078251","journal-title":"Parkinson's Disease"},{"key":"1286_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/abbs\/gmab055","volume":"53","author":"LI Dong","year":"2021","unstructured":"Dong LI, Zheng Y, Gao L, Luo X (2021) LncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced parkinson\u2019s disease by impairing miR-374c-5p. Acta Biochim Biophys Sin 53:870\u2013882. https:\/\/doi.org\/10.1093\/abbs\/gmab055","journal-title":"Acta Biochim Biophys Sin"},{"key":"1286_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12017-014-8294-x","volume":"16","author":"GS Gaki","year":"2014","unstructured":"Gaki GS, Papavassiliou AG (2014) Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson\u2019s disease. Neuromol Med 16:217\u2013230. https:\/\/doi.org\/10.1007\/s12017-014-8294-x","journal-title":"Neuromol Med"},{"key":"1286_CR10","first-page":"2127","volume":"8","author":"X Gong","year":"2016","unstructured":"Gong X, Wang H, Ye Y, Shu Y, Deng Y, He X, Lu G, Zhang S (2016) Mir-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK\/mTOR pathway in parkinson\u2019s disease. Am J Transl Res 8:2127\u20132137","journal-title":"Am J Transl Res"},{"key":"1286_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00249-y","volume":"10","author":"S He","year":"2021","unstructured":"He S, Huang L, Shao C, Nie T, Xia L, Cui B, Lu F, Zhu L, Chen B, Yang Q (2021) Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease. Transl Neurodegener 10:25. https:\/\/doi.org\/10.1186\/s40035-021-00249-y","journal-title":"Transl Neurodegener"},{"key":"1286_CR12","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11011-021-00835-z","volume":"36","author":"H Huang","year":"2021","unstructured":"Huang H, Zheng S, Lu M (2021a) Downregulation of lncRNA MEG3 is involved in Parkinson\u2019s disease. Metab Brain Dis 36:2323\u20132328. https:\/\/doi.org\/10.1007\/s11011-021-00835-z","journal-title":"Metab Brain Dis"},{"key":"1286_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3285","volume":"23","author":"FK Huang","year":"2021","unstructured":"Huang FK, Zheng CY, Huang LK, Lin CQ, Zhou JF, Wang JX (2021b) Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1. J Gene Med 23:e3285. https:\/\/doi.org\/10.1002\/jgm.3285","journal-title":"J Gene Med"},{"issue":"1","key":"1286_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08668-w","volume":"21","author":"W Kong","year":"2021","unstructured":"Kong W, Li H, Xie L, Cui G, Gu W, Zhang H, Ma W, Zhou Y (2021) LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p\/RAB22A axis. BMC Cancer 21(1):1069. https:\/\/doi.org\/10.1186\/s12885-021-08668-w","journal-title":"BMC Cancer"},{"key":"1286_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0278-5846(03)00019-8","volume":"27","author":"N Lev","year":"2003","unstructured":"Lev N, Melamed E, Offen D (2003) Apoptosis and parkinson\u2019s disease. Progress in neuro-psychopharmacology &. Biol Psychiatry 27:245\u2013250. https:\/\/doi.org\/10.1016\/s0278-5846(03)00019-8","journal-title":"Biol Psychiatry"},{"key":"1286_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s13760-023-02388-7","volume":"124","author":"X Lin","year":"2024","unstructured":"Lin X, Tao T, He X, Mao L, Pan L, Chen L (2024) LncRNA MEG8 ameliorates parkinson\u2019s disease neuro-inflammation through miR-485-3p\/FBXO45 axis. Acta Neurol Belg 124:549\u2013557. https:\/\/doi.org\/10.1007\/s13760-023-02388-7","journal-title":"Acta Neurol Belg"},{"key":"1286_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11064-020-03157-1","volume":"46","author":"T Liu","year":"2021","unstructured":"Liu T, Zhang Y, Liu W, Zhao J (2021) LncRNA NEAT1 regulates the development of Parkinson\u2019s disease by targeting AXIN1 via sponging miR-212-3p. Neurochem Res 46:230\u2013240. https:\/\/doi.org\/10.1007\/s11064-020-03157-1","journal-title":"Neurochem Res"},{"key":"1286_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/17085381211019510","volume":"30","author":"Q Liu","year":"2022","unstructured":"Liu Q, Yan S, Yuan Y, Ji S, Guo L (2022) Mir-28-5p improved carotid artery stenosis by regulating vascular smooth muscle cell proliferation and migration. Vascular 30:764\u2013770. https:\/\/doi.org\/10.1177\/17085381211019510","journal-title":"Vascular"},{"key":"1286_CR19","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3892\/ijmm.2020.4685","volume":"46","author":"L Ma","year":"2020","unstructured":"Ma L, Zhang Y, Hu F (2020) miR\u201328\u20135p inhibits the migration of breast cancer by regulating WSB2. Int J Mol Med 46:1562\u20131570. https:\/\/doi.org\/10.3892\/ijmm.2020.4685","journal-title":"Int J Mol Med"},{"key":"1286_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2022.111691","volume":"206","author":"C Morsiani","year":"2022","unstructured":"Morsiani C, Bacalini MG, Collura S, Moreno-Villanueva M, Breusing N, B\u00fcrkle A, Grune T, Franceschi C, De Eguileor M, Capri M (2022) Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in down syndrome. Mech Ageing Dev 206:111691. https:\/\/doi.org\/10.1016\/j.mad.2022.111691","journal-title":"Mech Ageing Dev"},{"key":"1286_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2741\/4776","volume":"24","author":"S Oe","year":"2019","unstructured":"Oe S, Kimura T, Yamada H (2019) Regulatory non-coding RNAs in nervous system development and disease. Front Bioscience (Landmark edition) 24:1203\u20131240. https:\/\/doi.org\/10.2741\/4776","journal-title":"Front Bioscience (Landmark edition)"},{"key":"1286_CR22","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.18632\/aging.204795","volume":"15","author":"H Ou","year":"2023","unstructured":"Ou H, Qian Y, Ma L (2023) MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p\/FGF2 axis. Aging 15:6100\u20136116. https:\/\/doi.org\/10.18632\/aging.204795","journal-title":"Aging"},{"key":"1286_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.18071\/isz.76.0189","volume":"76","author":"B Ozdilek","year":"2023","unstructured":"Ozdilek B, Kaya Alper I, Demircan B, Tombul T, Ankarali H (2023) Clinical significance of serum LncRNA H19, GAS5, HAR1B and linc01783 levels in parkinson\u2019s disease. Ideggyogyaszati Sz 76:189\u2013196. https:\/\/doi.org\/10.18071\/isz.76.0189","journal-title":"Ideggyogyaszati Sz"},{"key":"1286_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","volume":"38","author":"P Poprac","year":"2017","unstructured":"Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M (2017) Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci 38:592\u2013607. https:\/\/doi.org\/10.1016\/j.tips.2017.04.005","journal-title":"Trends Pharmacol Sci"},{"key":"1286_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"1286_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353:777\u2013783. https:\/\/doi.org\/10.1126\/science.aag2590","journal-title":"Science"},{"key":"1286_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113132","volume":"417","author":"Q Sun","year":"2022","unstructured":"Sun Q, Zhang Y, Wang S, Yang F, Cai H, Xing Y, Zhou L, Chen S, Wang Y (2022) LncRNA HOTAIR promotes \u03b1-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in parkinson\u2019s disease. Exp Cell Res 417:113132. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113132","journal-title":"Exp Cell Res"},{"key":"1286_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11064-021-03230-3","volume":"46","author":"C Xin","year":"2021","unstructured":"Xin C, Liu J (2021) Long non-coding RNAs in Parkinson\u2019s disease. Neurochem Res 46:1031\u20131042. https:\/\/doi.org\/10.1007\/s11064-021-03230-3","journal-title":"Neurochem Res"},{"key":"1286_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21342","volume":"9","author":"M Xu","year":"2023","unstructured":"Xu M, Zheng J, Wang J, Huang H, Hu G, He H (2023) MCF2L-AS1\/miR-874-3p\/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance. Heliyon 9:e21342. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21342","journal-title":"Heliyon"},{"key":"1286_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0318-z","volume":"51","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Hu C, Huang J, Liu W, Lai W, Leng F, Tang Q, Liu Y, Wang Q, Zhou M, Sheng F, Li G, Zhang R (2019) ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in parkinson\u2019s disease. Exp Mol Med 51:1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0318-z","journal-title":"Exp Mol Med"},{"key":"1286_CR31","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e75","volume":"33","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yang L, Wang J, Li Y, Chen Y (2022) SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1\/IGF2\/MEK\/ERK axis. J Gynecol Oncol 33:e75. https:\/\/doi.org\/10.3802\/jgo.2022.33.e75","journal-title":"J Gynecol Oncol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-025-01286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-025-01286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:25:55Z","timestamp":1765549555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-025-01286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1007\/s13365-025-01286-3","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have obtained\n                      The Sixth Hospital of Wuhan\n                      ,\n                      Affiliated Hospital of Jianghan University\n                      review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}